methyl (1R,15S,17R,19S,20S)-6,18-dimethoxy-17-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 育亨宾生物碱
• 英文名称: methyl (1R,15S,17R,19S,20S)-6,18-dimethoxy-17-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
• 化学式: C₃₅H₄₂N₂O₉
• 分子量: 634.7
• InChiKey: SZLZWPPUNLXJEA-RJQPPZSPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  46
• 可旋转键数：
  11
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.49
• 拓扑面积：
  118
• 氢给体数：
  1
• 氢受体数：
  10

文献信息

• Identification of small molecules that facilitate therapeutic exon skipping
  申请人：The Regents of the University of California

  公开号：US10188633B2

  公开（公告）日：2019-01-29

  This invention relates, e.g., to a method for enhancing exon skipping in a pre-mRNA of interest, comprising contacting the pre-mRNA with an effective amount of a small molecule selected from the compounds shown in Table 1, or a pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof, and, optionally, with an antisense oligonucleotide that is specific for a splicing sequence in the pre-mRNA Methods for treating Duchenne muscular dystrophy (DMD) are disclosed.

  本发明涉及一种增强相关前mRNA中外显子跳越的方法，该方法包括使前mRNA与有效量的选自表1所示化合物的小分子或其药学上可接受的盐、水合物、溶液或异构体接触，以及与针对前mRNA中剪接序列特异的反义寡核苷酸接触。
• IDENTIFICATION OF SMALL MOLECULES THAT FACILITATE THERAPEUTIC EXON SKIPPING
  申请人：Nelson Stanley F.

  公开号：US20140080896A1

  公开（公告）日：2014-03-20

  This invention relates, e.g., to a method for enhancing exon skipping in a pre-mRNA of interest, comprising contacting the pre-mRNA with an effective amount of a small molecule selected from the compounds shown in Table 1, or a pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof, and, optionally, with an antisense oligonucleotide that is specific for a splicing sequence in the pre-mRNA Methods for treating Duchenne muscular dystrophy (DMD) are disclosed.